ACADIA Pharmaceuticals Inc.
ACAD · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $72 | $27 | $19 | $144 |
| Dep. & Amort. | $3 | -$1 | $3 | $5 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $13 | $14 | $11 | $10 |
| Change in WC | -$13 | $22 | -$11 | $30 |
| Other Non-Cash | -$1 | $3 | -$2 | -$149 |
| Operating Cash Flow | $74 | $64 | $20 | $40 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | $99 | -$99 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$205 | -$174 | -$156 | -$136 |
| Inv. Sales/Matur. | $126 | $131 | $131 | $112 |
| Other Inv. Act. | $0 | -$99 | $0 | $147 |
| Investing Cash Flow | -$79 | -$43 | -$124 | $122 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $9 | $16 | $2 | $2 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $9 | $16 | $2 | $2 |
| Forex Effect | $0 | $0 | -$0 | -$0 |
| Net Chg. in Cash | $4 | $37 | -$102 | $164 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $263 | $226 | $328 | $164 |
| End Cash | $267 | $263 | $226 | $328 |
| Free Cash Flow | $74 | $162 | -$79 | $40 |